🟢 Advanced Biomed is trading 10% up today with no confirmed company-specific catalyst

Advanced Biomed is trading at $4.28, up 10.03%, with no confirmed company-specific announcement explaining the October 19 move.

• A past report about ending a $25 million security purchase agreement is not a confirmed new catalyst for this session.
• Biotech is stronger, with XBI up 2.09%; Merck KGaA’s announced acquisition of Silence Therapeutics adds sector M&A context but does not establish a direct cause.
• The available source lists pre-market volume of 28,278, not current-session volume, so live activity cannot be confirmed.